Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study

BACKGROUND: Response Evaluation Criteria in Solid Tumors (RECIST) are widely used to assess the effect of chemotherapy in patients with cancer. We hypothesised that the change in unidimensional tumour size handled as a continuous variable was more reliable than RECIST in predicting overall survival...

Descripción completa

Detalles Bibliográficos
Autores principales: Toffart, Anne-Claire, Moro-Sibilot, Denis, Couraud, Sébastien, Merle, Patrick, Perol, Maurice, Girard, Nicolas, Souquet, Pierre-Jean, Mastroianni, Bénédicte, Ferretti, Gilbert R, Romand, Philippe, Chatellain, Patrick, Vesin, Aurélien, Brambilla, Elisabeth, Brambilla, Christian, Timsit, Jean-François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364468/
https://www.ncbi.nlm.nih.gov/pubmed/25527907
http://dx.doi.org/10.1186/1471-2407-14-989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364468/
https://www.ncbi.nlm.nih.gov/pubmed/25527907
http://dx.doi.org/10.1186/1471-2407-14-989

Ejemplares similares